MeSH Browser

MeSH Supplementary: sacubitril and valsartan sodium hydrate drug combination
Unique ID: C549068
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C549068
Entry Term(s): 3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate; Entresto; LCZ 696; LCZ-696; LCZ696; sacubitril and valsartan drug combination; sacubitril and valsartan sodium anhydrous drug combination; sacubitril valsartan drug combination; sacubitril valsartan sodium anhydrous; sacubitril valsartan sodium hydrate; sacubitril-valsartan; sacubitril-valsartan sodium anhydrous drug combination; sacubitril-valsartan sodium hydrate drug combination; trisodium (3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate) hemipentahydrate
Pharm Action: Angiotensin Receptor Antagonists
Registry Numbers: WB8FT61183; 0; 51T0V5Z5AD
Related Numbers: 51T0V5Z5AD
Heading Mapped to: *Aminobutyrates; *Biphenyl Compounds; Drug Combinations; *Valsartan
Frequency: 930
Note: an angiotensin II receptor antagonist
Source: Lancet 2010 Apr 10;375(9722):1255-66
Date of Entry: 2010/05/02
Revision Date: 2021/05/14

sacubitril and valsartan sodium hydrate drug combination MeSH Supplementary Concept Data 2025